Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androxal in Idiopathic Male Infertility
NCT02160704Phase 3Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enclomiphene in idiopathic male infertility (IMI), sponsored by Baylor College of Medicine. Planned start Sep 2014; status: withdrawn.
02
Drugs
enclomiphene
03
Conditions
idiopathic male infertility (IMI)
Beyond the preview
Go deeper on NCT02160704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160704.